Perrigo CEO to retire

Perrigo CEO to retire

DUBLIN — Perrigo is looking for a new CEO. The company announced Monday that it had launched a search ahead of current CEO John Hendrickson’s retirement.

Hendrickson currently is planning on staying until his replacement is appointed, as well as up to 60 days after to ensure a smooth transition. Hendrickson plans to stand for election to the board of directors at Perrigo’s Annual General Meeting on July 20, and will step down once the new CEO is appointed, the company said.

“My decision to retire this year has not been an easy one, but now is the right time for me to make this change personally and professionally,” Hendrickson said. “I am privileged to have led Perrigo, particularly as we’ve met the challenges we faced and stabilized the business in a time of transition. I am extraordinarily proud of what we have accomplished since I joined the Company in 1989. I am confident the company will successfully execute on our strategic plan to return to consolidated growth in 2018 and to advance our commitment to providing Quality Affordable Healthcare Products to customers and consumers around the world. I look forward to continuing to work alongside our tremendous leadership team until we’ve successfully transitioned to my successor.”

Hendrickson was named CEO in April 2016 and joined Perrigo’s board in June 2016. He has held such positions at Perrigo as EVP global operations and supply chain, EVP and GM of Perrigo Consumer Healthcare, EVP operations, VP manufacturing VP customer service, among others, during his more than 25 years with the company.

Board chairman Laurie Brlas said that Hendrickson’s tenure as CEO has seen him taking action in four key areas — organization improvements, enhancing Perrigo’s leadership, focusing on its international consumer healthcare business and overseeing the company’s strategic portfolio review, which included divesting certain assets.

“The board is grateful to John for his 25-plus years of service to the Company and we look forward to partnering with him to continue on the outstanding progress of the past year while we work to identify his successor,” Brlas said. “The board and I have no doubt about the strength of Perrigo’s business and that we will carry this momentum forward over the next few months of John’s leadership and beyond under a new executive. We will retain an executive search firm to support our thorough search for Perrigo’s next leader who can continue to build on our upward trajectory.”

June 6, 2017

Source: http://www.drugstorenews.com/

June 6, 2017 / Pharma News